KOREA WHO

Lee Jae-young is the CEO and President of Bukwang Pharmaceutical. He also serves as Executive Vice President of Strategic Planning at OCI Holdings.

Lee has focused on improving Bukwang Pharmaceutical’s profitability, with particular emphasis on its central nervous system (CNS) pharmaceutical business.

He was born on January 29, 1974.

Lee graduated from Hyundai High School in Seoul and earned a degree in Business Administration from Seoul National University. He later obtained an LLM from Columbia Law School in the United States.

After passing the 40th bar exam, Lee worked as a prosecutor at the Seoul District Prosecutors’ Office, Chuncheon District Prosecutors’ Office, and the Daejeon High Prosecutors’ Office. In 2019, he transitioned to corporate management, becoming a managing director of business planning at OCI Holdings.

In 2023, he was promoted to Executive Vice President of Strategic Planning at OCI Holdings. The following year, in 2024, he was appointed CEO and President of Bukwang Pharmaceutical.

Lee transformed Bukwang Pharmaceutical’s business structure by shifting the focus to contract sales organizations (CSOs) and establishing the CNS Business Division directly under the CEO’s office. He also prioritized the marketing of 'Latuda', a CNS drug. These efforts contributed to Bukwang Pharmaceutical’s return to profitability in the third quarter of 2024.


#LeeJaeyoung #BukwangPharmaceutical #OCIHoldings #CNSBusiness #Latuda #CorporateManagement #KoreanPharmaceuticals #Profitability #BusinessStrategy #ColumbiaLawSchool #SNU